02 November 2026 ASX Supervision Level 45, South Tower, Rialto 525 Collins Street Melbourne VIC 3000 By email: [email protected]. RESPONSE TO PRICE QUERY 4DMedical Limited (“4DX” or the “Company”) responds to the letter received from the Australian Securities Exchange...
Response to ASX Price Query
Filed with ASX ·
6ix is reading this filing.
Earlier from 4DMedical
- Pause in Trading
- Quarterly Activity Report and Appendix 4C
- FY2026 Full year results
- Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
- US Bill directs VA to adopt 4D lung imaging
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical